CYTORI THERAPEUTICS, INC. (26)
Browse by Contract Category
Contracts
-
Distribution Agreement, dated October 23, 2020, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC
(Filed With SEC on October 23, 2020)
-
Registration Rights Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on October 6, 2020)
-
Plus Therapeutics, Inc., 2020 Equity Incentive Plan
(Filed With SEC on June 17, 2020)
-
Patent and Know-How License Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and NanoTx, Corp
(Filed With SEC on March 30, 2020)
-
Description of Securities
(Filed With SEC on March 30, 2020)
-
Purchase Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on October 6, 2020)
-
Form of Underwriter Warrant Amendment Agreement
(Filed With SEC on October 5, 2020)
-
Amended and Restated Employment Agreement between Andrew Sims and Plus Therapeutics, Inc
(Filed With SEC on May 14, 2020)
-
Amended and Restated Employment Agreement between Marc Hedrick and Plus Therapeutics, Inc
(Filed With SEC on May 14, 2020)
-
Form of Warrant Amendment Agreement
(Filed With SEC on April 23, 2020)
-
Ninth Amendment to the Loan and Security Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and Oxford Finance LLC
(Filed With SEC on March 30, 2020)
-
Second Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated February 6, 2020
(Filed With SEC on March 30, 2020)
-
Employment Agreement between Plus Therapeutics, Inc. and Marc Hedrick
(Filed With SEC on March 12, 2020)
-
Employment Agreement between Plus Therapeutics, Inc. and Andrew Sims
(Filed With SEC on March 12, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on February 6, 2020)
-
Form of Series V Warrant
(Filed With SEC on September 16, 2019)
-
Form of Series U Warrant
(Filed With SEC on September 16, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on September 16, 2019)
-
2014 Equity Incentive Plan of Plus Therapeutics, Inc., as Amended and Restated
(Filed With SEC on August 15, 2019)
-
Eighth Amendment to Loan and Security Agreement, effective as of July 15, 2019, by and between Plus Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on August 15, 2019)
-
Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on August 15, 2019)
-
Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on May 14, 2019)
-
Asset and Share Sale and Purchase Agreement, dated as of April 19, 2019, by and between Cytori Therapeutics, Inc. and Seijir Shirahama
(Filed With SEC on April 23, 2019)
-
Sixth Amendment to Loan and Security Agreement dated March 4, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on March 29, 2019)
-
Fifth Amendment to Loan and Security Agreement dated February 13, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on March 29, 2019)
-
Fourth Amendment to Loan and Security Agreement dated December 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC
(Filed With SEC on February 1, 2019)